Sudeep Pharma IPO Allotment Status Completed; Listing Date Confirmed for Tomorrow on NSE & BSE

Vadodara, November 27: Sudeep Pharma IPO allotment status has been completed, and investors who applied can check their allotment status on NSE, BSE, or on the website of the registrar, which is MUFG Intime India Private Limited. Furthermore, the company has confirmed that its shares will list on NSE and BSE tomorrow, on November 28.

How to Check Sudeep Pharma IPO Allotment Status on NSE

Step 1: Visit: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

Step 2: Enter your PAN.

Step 3: Complete the verification if required.

Step 4: After verification, the system will display your allotment status.

How to Check Sudeep Pharma IPO Allotment Status on BSE

Step 1: Visit: https://www.bseindia.com/investors/appli_check.aspx

Step 2: Under Issue Type, select Equity.

Step 3: Under Issue Name, choose Sudeep Pharma Limited once it appears.

Step 4: Enter your Application Number or PAN.

Step 5: Complete the captcha.

Step 6: Click Search to view the allotment result.

How to Check Sudeep Pharma IPO Allotment Status on Registrar Website (MUFG Intime)

Step 1: Go to: https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Step 2: Select Sudeep Pharma Limited from the dropdown list of active IPOs.

Step 3: Choose your preferred search method: PAN, DP ID / Client ID, Application Number

Step 4: Enter the required details as prompted.

Step 5: Complete the captcha verification.

Step 6: Click Submit to view your allotment status.

Sudeep Pharma IPO Key Details

The ₹895 crore Sudeep Pharma IPO is a combination of fresh issue of 0.16 crore shares aggregating to ₹95 crores and offer for sale of 1.35 crore shares aggregating to ₹800 crores. Sudeep Pharma IPO price band is at ₹562 to ₹593 per share. The lot size is 25 shares per application, with a minimum investment amount by a retail investor at ₹14,825 (25 shares) at the upper price band. ICICI Securities Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.

Sudeep Pharma IPO Subscription Status Highlights

Sudeep Pharma IPO was subscribed by a total of 93.71 times. QIBs subscribed to the IPO with the highest factor of 213.08 times, followed by Non-Institutional Buyers by 116.72 times, and retail investors by 15.65 times.

Sudeep Pharma IPO: Anchor Allocation

Ahead of the IPO, Sudeep Pharma raised ₹268.5 crore from anchor investors by allocating them 45,27,823 shares at ₹593 per share. Key investors included SBI Mutual Fund (MF), HDFC MF, ICICI Prudential MF, Nippon India MF, WhiteOak Capital MF, Aditya Birla Sun Life MF, Motilal Oswal MF, Quant MF, Bandhan MF, UTI MF, Edelweiss MF, Tata AIA Life Insurance and SBI Life Insurance.

What’s Ahead for Sudeep Pharma IPO?

The allotment status of Sudeep Pharma IPO has been completed. Investors can now check whether they have received the allotment. The company will credit the shares and initiate refunds today, on November 27. With the company confirming the listing for tomorrow, investors who received the allotment will hope for a stellar listing.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations